* Codexis Inc CDXS.OQ reported a quarterly adjusted loss
of 50
cents per share for the quarter ended in September, lower than
the same quarter last year, when the company reported EPS of -15
cents. The mean expectation of seven analysts for the quarter
was for a loss of 32 cents per share. Wall Street expected
results to range from -37 cents to -27 cents per share.
* Revenue fell 73.1% to $9.28 million from a year ago;
analysts
expected $10.03 million.
* Codexis Inc's reported EPS for the quarter was a loss
of 50
cents.
* The company reported a quarterly loss of $34.91 million.
* Codexis Inc shares had fallen by 12.2% this quarter and
lost 64.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 4.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Codexis Inc is
$6.00
This summary was machine generated from LSEG data November 2 at
09:54 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 -0.32 -0.50 Missed
Jun. 30 2023 -0.21 -0.17 Beat
Mar. 31 2023 -0.31 -0.34 Missed
Dec. 31 2022 -0.23 -0.14 Beat